GlassScriptPhysician profile
Berkeley Graham Bate
NPI 1891969713
$3,010.45
in general payments reported to CMS, 2019-2025
9 companies · $1,553 in 2025
The $1,553 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.55 · 2020: $43.96 · 2021: $220 · 2022: $215 · 2023: $361 · 2024: $564 · 2025: $1,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325 · Travel and Lodging: $1,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.95 |
| Travel and Lodging | $1,153.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,442.39 | 2021-2025 | Cd Horizon Spinal System, Plasmablade(Tm) |
| Centinel Spine, LLC | $435.20 | 2024 | Prodisc C Vivo, Prodisc L |
| Boston Scientific Corporation | $330.84 | 2020-2025 | Intracept, General - Pain Management, Coveredge 32 |
| Cerapedics INC. | $316.02 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $277.24 | 2023-2025 | Vivigen Mis Delivery System, Arch, Teligen |
| Stryker Corporation | $128.97 | 2024 | Sonopet Iq |
| Nevro Corp. | $37.01 | 2019 | |
| Merck Sharp & Dohme LLC | $30.29 | 2019-2022 | |
| Relievant Medsystems, INC. | $12.49 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Berkeley Bate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.